A Trial to Assess the Safety, Tolerability, and Pharmacokinetics of MDT-637 in Healthy Volunteers

NCT01355016 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

48

Enrollment

INDUSTRY

Sponsor class

Conditions

Drug Safety
Respiratory Syncytial Virus Infections

Interventions

DRUG: MDT-637

Sponsor

MicroDose Therapeutx, Inc